Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 131

1.

Gastrointestinal viral load and enteroendocrine cell number are associated with altered survival in HIV-1 infected individuals.

van Marle G, Sharkey KA, Gill MJ, Church DL.

PLoS One. 2013 Oct 16;8(10):e75967. doi: 10.1371/journal.pone.0075967. eCollection 2013.

2.

Higher levels of Zidovudine resistant HIV in the colon compared to blood and other gastrointestinal compartments in HIV infection.

van Marle G, Church DL, Nunweiler KD, Cannon K, Wainberg MA, Gill MJ.

Retrovirology. 2010 Sep 13;7:74. doi: 10.1186/1742-4690-7-74.

3.

HIV-1 Genetic Diversity and Its Impact on Baseline CD4+T Cells and Viral Loads among Recently Infected Men Who Have Sex with Men in Shanghai, China.

Li X, Xue Y, Cheng H, Lin Y, Zhou L, Ning Z, Wang X, Yu X, Zhang W, Shen F, Zheng X, Gai J, Li X, Kang L, Nyambi P, Wang Y, Zhuang M, Pan Q, Zhuang X, Zhong P.

PLoS One. 2015 Jun 29;10(6):e0129559. doi: 10.1371/journal.pone.0129559. eCollection 2015.

4.

Effect of raltegravir intensification on HIV proviral DNA in the blood and gut mucosa of men on long-term therapy: a randomized controlled trial.

Chege D, Kovacs C, la Porte C, Ostrowski M, Raboud J, Su D, Kandel G, Brunetta J, Kim CJ, Sheth PM, Kaul R, Loutfy MR.

AIDS. 2012 Jan 14;26(2):167-74. doi: 10.1097/QAD.0b013e32834e8955.

PMID:
22089379
6.

Evaluation of the effectiveness of highly active antiretroviral therapy in persons with human immunodeficiency virus using biomarker-based equivalence of disease progression.

Jacobson LP, Li R, Phair J, Margolick JB, Rinaldo CR, Detels R, Muñoz A.

Am J Epidemiol. 2002 Apr 15;155(8):760-70.

PMID:
11943695
7.

Immunoarchitecture of lymphoid tissue in HIV-infection during antiretroviral therapy correlates with viral persistence.

Alòs L, Navarrete P, Morente V, Garcia F, Garrido M, Plana M, Mozos A, López A, Gil C, Pumarola T, Caballero M, Blanch JL, Fumero E, Miró JM, Gallart T, Gatell JM, Campo E.

Mod Pathol. 2005 Jan;18(1):127-36.

9.

Cd38 expression on Cd8+ T cells in Human immunodeficiency virus 1-positive adults treated with HAART.

Beran O, Holub M, Spála J, Kalanin J, Stanková M.

Acta Virol. 2003;47(2):121-4.

PMID:
14524479
10.

Plasma levels of viro-immunological markers in HIV-infected and non-infected Ethiopians: correlation with cell surface activation markers.

Messele T, Brouwer M, Girma M, Fontanet AL, Miedema F, Hamann D, Rinke de Wit TF.

Clin Immunol. 2001 Feb;98(2):212-9.

PMID:
11161977
11.

Study of the impact of HIV genotypic drug resistance testing on therapy efficacy.

Van Vaerenbergh K.

Verh K Acad Geneeskd Belg. 2001;63(5):447-73. Review.

PMID:
11813503
12.
13.

[The prognostic markers of survival and progression in HIV-1 infection. A study of CD4+ lymphocytes, antigen p24 and viral load during 3 years in a cohort of 251 patients].

Rubio Caballero M, Nogués Biau A, Falguera Sacrest M, Puig Ganau T, Lecha N, Rubio Rivas C.

An Med Interna. 2000 Oct;17(10):533-7. Spanish.

PMID:
11109648
14.

The CD8⁺ memory stem T cell (T(SCM)) subset is associated with improved prognosis in chronic HIV-1 infection.

Ribeiro SP, Milush JM, Cunha-Neto E, Kallas EG, Kalil J, Somsouk M, Hunt PW, Deeks SG, Nixon DF, SenGupta D.

J Virol. 2014 Dec;88(23):13836-44. doi: 10.1128/JVI.01948-14. Epub 2014 Sep 24.

15.

Responsiveness of T cells to interleukin-7 is associated with higher CD4+ T cell counts in HIV-1-positive individuals with highly active antiretroviral therapy-induced viral load suppression.

Camargo JF, Kulkarni H, Agan BK, Gaitan AA, Beachy LA, Srinivas S, He W, Anderson S, Marconi VC, Dolan MJ, Ahuja SK.

J Infect Dis. 2009 Jun 15;199(12):1872-82. doi: 10.1086/598858.

16.

HIV-1 Nef sequence and functional compartmentalization in the gut is not due to differential cytotoxic T lymphocyte selective pressure.

Lewis MJ, Frohnen P, Ibarrondo FJ, Reed D, Iyer V, Ng HL, Elliott J, Yang OO, Anton P.

PLoS One. 2013 Sep 13;8(9):e75620. doi: 10.1371/journal.pone.0075620. eCollection 2013.

18.

Role of antiretroviral therapies in mucocutaneous manifestations in HIV-infected children over a period of two decades.

Seoane Reula E, Bellon JM, Gurbindo D, Muñoz-Fernandez MA.

Br J Dermatol. 2005 Aug;153(2):382-9.

PMID:
16086754
19.

Early and late HIV-1 RNA level and its association with other markers and disease progression in long-term AIDS-free homosexual men.

Spijkerman IJ, Prins M, Goudsmit J, Veugelers PJ, Coutinho RA, Miedema F, de Wolf F.

AIDS. 1997 Sep;11(11):1383-8.

PMID:
9302449
20.

Supplemental Content

Support Center